Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

Presentation THT 2026

Emyosound Real-Time 3D Myocardial Shear Wave Elastography for Quantitative Assessment of Cardiac Stiffness in Heart Failure and Cardiomyopathies

Presenter: Thierry Sarda

March 04, 2026

Presentation THT 2026

When the Family History Doesn’t Help: Case-Based Exploration of Inherited Cardiomyopathies

Presenter: Lindsey Aurora

March 03, 2026

Presentation THT 2026

LVADs to Jumpstart the Process of Myocardial Regeneration

Presenter: Stavros G. Drakos

March 02, 2026

Presentation THT 2026

The CHILD Trial: Phase I Randomized Study of Cardiac Stem Cells in Patients with Hypoplastic Left Heart Syndrome

Presenter: Sunjay Kaushal

March 02, 2026

Presentation THT 2026

Implantation of iPS Cells Differentiated into Cardiomyocytes to Repair the Damaged Myocardium

Presenter: Eugene Jiaxian Wang

March 02, 2026

Presentation THT 2026

Cardiac Reprogramming Cocktail Delivered in a Single Adeno-Associated Virus to Improve Function in a Porcine Model of Ischemic Heart Failure

Presenter: Kathy Ivey

March 02, 2026

Presentation THT 2026

Inducing Cardiomyocyte Proliferation Using Native Cell Cycle Pathways to Create More Cardiomyocytes

Presenter: James F. Martin

March 02, 2026

Presentation THT 2026

Treating Danon Disease with Gene Therapy: Lessons Learned and Prospects for the Future

Presenter: Eric D. Adler

March 02, 2026

Presentation THT 2026

Overview of Gene Therapies for Specific Cardiomyopathies

Presenter: Barry Greenberg

March 02, 2026

News Conference News THT 2026

THT 2026: What to Expect in Boston

Todd Neale

February 23, 2026

Presentation THT 2023

Applications of Gene Therapy in Cardiomyopathies (TBD)

Presenter: Eric Adler

March 20, 2023

Presentation THT 2022

Featured Lecture: Medical Therapies for Amyloid

Presenter: Matthew Maurer

February 01, 2022

Presentation THT 2022

Percutaneous and Surgical Approaches for Hypertrophic Obstructive Cardiomyopathies

Presenter: Srihari Naidu

February 01, 2022

Presentation THT 2022

Novel Drug Therapies for HCM

Presenter: Carolyn Ho

February 01, 2022

Presentation THT 2022

Results From First-In-Human Clinical Trial of RP-A501 (AAV9:LAMP2B) Gene Therapy Treatment for Danon Disease

Presenter: Barry Greenberg

February 01, 2022

Presentation THT 2022

The Role of Genetic Testing in Heart Failure (When Should You Order It)

Presenter: W. H. Wilson Tang

February 01, 2022

Advertisement

Emyosound Real-Time 3D Myocardial Shear Wave Elastography for Quantitative Assessment of Cardiac Stiffness in Heart Failure and Cardiomyopathies

When the Family History Doesn’t Help: Case-Based Exploration of Inherited Cardiomyopathies

LVADs to Jumpstart the Process of Myocardial Regeneration

The CHILD Trial: Phase I Randomized Study of Cardiac Stem Cells in Patients with Hypoplastic Left Heart Syndrome

Implantation of iPS Cells Differentiated into Cardiomyocytes to Repair the Damaged Myocardium

Cardiac Reprogramming Cocktail Delivered in a Single Adeno-Associated Virus to Improve Function in a Porcine Model of Ischemic Heart Failure

Inducing Cardiomyocyte Proliferation Using Native Cell Cycle Pathways to Create More Cardiomyocytes

Treating Danon Disease with Gene Therapy: Lessons Learned and Prospects for the Future

Overview of Gene Therapies for Specific Cardiomyopathies

THT 2026: What to Expect in Boston

Applications of Gene Therapy in Cardiomyopathies (TBD)

Featured Lecture: Medical Therapies for Amyloid

Percutaneous and Surgical Approaches for Hypertrophic Obstructive Cardiomyopathies

Novel Drug Therapies for HCM

Results From First-In-Human Clinical Trial of RP-A501 (AAV9:LAMP2B) Gene Therapy Treatment for Danon Disease

The Role of Genetic Testing in Heart Failure (When Should You Order It)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content